BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and include all adjustments that, in the opinion of management, are necessary for a fair presentation of the results of the periods presented. All such adjustments are considered of a normal recurring nature. Quarterly results of operations are not necessarily indicative of annual results.

Certain footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted. The condensed consolidated balance sheet as of December 31, 2024 was derived from the audited consolidated balance sheet at that date. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of TruBridge, Inc. (“TruBridge” or the “Company”) for the year ended December 31, 2024 and the notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Reportable Segments Presentation Changes

In May 2024, the Company realigned its reporting structure due to certain organizational changes. As a result, the Company changed from three reportable segments of (i) Revenue Cycle Management (“RCM”), (ii) Electronic Health Records (“EHR”), and (iii) Patient Engagement to two reportable segments of (i) RCM and (ii) EHR. The Patient Engagement segment results have been transitioned into the EHR segment. As part of the realignment, the reportable segment naming convention was updated. The previously reported RCM segment has been updated to Financial Health, and the former EHR segment has been updated to Patient Care. The change is intended to improve connectivity and alignment between the two business units to better serve our clients and more accurately reflect how the Company’s management views and operates the business. All prior segment information has been recast to reflect the Company's new segment structure and current period presentation. Refer to Note 17 - Segment Reporting for more information.

Revision of Previously Issued Financial Statements

During the year ended December 31, 2024, the Company reversed revenue from customers that was recognized improperly during the prior year. The Company assessed the materiality of this error on prior period consolidated financial statements in accordance with the SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in the Current Year Financial Statements.” In its assessment, the Company concluded based on quantitative and qualitative analysis that this error was not material to the Company’s consolidated financial statements for the 2023 fiscal year or any interim periods therein.

Accordingly, the Company made corrections, as disclosed in the table below, to the condensed consolidated financial statements for the three months ended March 31, 2024:



(In thousands, except per share data)	As previously reported		Impact of revision		As adjusted
Condensed Consolidated Statement of Operations
Revenue:
Financial Health	$	53,038	$	401	$	53,439
Patient Care	30,209		469		30,678
Total revenue	$	83,247	$	870	$	84,117
Operating loss	(1,458)		870		(588)
Loss before taxes	(4,108)		870		(3,238)
Benefit from income taxes	(1,592)		208		(1,384)
Net loss	(2,516)		662		(1,854)
Net loss per share - basic	$	(0.17)	$	0.04	(0.13)
Net loss per share - diluted	$	(0.17)	$	0.04	(0.13)






Condensed Consolidated Statement of Comprehensive Income (Loss)
Net income (loss)	$	(2,516)	$	662	$	(1,854)
Comprehensive income (loss)	(2,403)		662		(1,741)

Condensed Consolidated Statement of Equity
Retained Earnings Balance at December 31, 2023	$	8,132	$	(2,645)	$	5,487
Total Stockholders’ Equity at December 31, 2023	186,618		(2,645)		183,973
Net income (loss)	(2,516)		662		(1,854)
Retained Earnings	5,616		(1,983)		3,633
Total Stockholders’ Equity at March 31, 2024	184,673		(1,983)		182,690

Condensed Consolidated Statement of Cash Flows
Net income (loss)	$	(2,516)	$	662	$	(1,854)
Accounts receivable	(4,112)		(870)		(4,982)
Income taxes, net	477		208		685

Principles of Consolidation

The condensed consolidated financial statements of TruBridge include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.

Subsequent Events

The Company has evaluated subsequent events through May 9, 2025, the date these condensed consolidated financial statements were issued. The Company concluded that no subsequent events have occurred that would require recognition or disclosure in the condensed consolidated financial statements other than what has been disclosed in these condensed consolidated financial statements and accompanying notes.